Bispecific Antibody Ivonescimab Added to Chemotherapy inEGFR-Variant Non–Small Cell Lung Cancer

Post time 8 hour(s) ago

journal：JAMA

Authors： ; Wenfeng Fang; Yuanyuan Zhao; Yongzhong Luo; Runxiang Yang; Yan Huang; Zhiyong He; Hui Zhao; Mingjun Li; Kai Li; Qibin Song; Xiaobo Du; Yulan Sun; Wei Li; Longhua Sun; Zhiyu Wang; Kunning Yang; Yun Fan; Baogang Liu; Hongyun Zhao; Ying Hu; Li Jia; Shen Xu; Tienan Yi; Dongqing Lv; Haitao Lan; Mengxia Li; Wenhua Liang; Yongsheng Wang; Hui Yang; Yuming Jia; Yuan Chen; Junguo Lu; Meiqi Shi; Chunling Liu; Ming Zhou; Jianya Zhou; Xianling Liu; Ningning Zhou; Ming He; Xiaorong Dong; Hualin Chen; Yongxing Chen; Haichuan Su; Xiaoling Li; Zhihong Zhang; Lei Yang; Ying Liu; Likun Chen; Xue Hou; Yu Zhang; Jun Guo; Ruiqiang Ma; Hong Lu; Di Wu; Weineng Feng; Wen Li; Jianan Huang; Yan Wang; Xia Song; Jiewen Peng; Laiyu Liu; Yubiao Guo; Wenting Li; Mengying Xia; Dongmei Lu; Mingxiu Hu; Zhongmin Maxwell Wang; Baiyong Li; Michelle Y. Xia; Li Zhang

Published date：--

DOI：10.1001/jama.2026.7745

PDF link：https://jamanetwork.com/journals ... 781198702.98521.pdf

Article link：https://doi.org/10.1001/jama.2026.7745

Article Source：American Medical Association (AMA)。

Remark：

[JAMA] Bispecific Antibody Ivonescimab Added to Chemotherapy inEGFR-Variant Non–Small Cell Lung Cancer

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] Bispecific Antibody Ivonescimab Added to Chemotherapy inEGFR-Variant Non–Small Cell Lung Cancer Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] Bispecific Antibody Ivonescimab Added to Chemotherapy inEGFR-Variant Non–Small Cell Lung Cancer